VMAT2 co-localizes with α-Syn protein in the Lewy bodies from PD brains [124], and overexpression of α-Syn negatively impairs VMAT2 expression/function, leading to increased levels of cytosolic monoamine in presynaptic terminals, which in turn induce neurotoxicity [113]. Here, SLC18A2 is linked to Parkinson disease.